阿斯利康：停产电晕疫苗：怀疑不良反应
2020年9月9日7:02 JST
根据STAT：
一名英国研究参与者怀疑有严重的不良反应。
9月8日，美国股市加班交易中，阿斯利康的ADR暂时下跌8.3％。
该报告不受欢迎：“与英国牛津大学共同开发的新型冠状病毒疫苗的3期试验已被搁置。”
彭博新闻社
https://www.bloomberg.co.jp/news/articles/2020-09-08/QGD081DWRGG001
AstraZeneca Covid-19 vaccine study is put on hold
A large, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca and the University of Oxford
at dozens of sites across the U.S. has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom.
A spokesperson for AstraZeneca,
a frontrunner in the race for a Covid-19 vaccine, said in a statement thatthe company’s “standard review process triggered a pause to vaccination to allow review of safety data.”
It was not immediately clear who placed the hold on the trial, though it is possible it was placed voluntarily by AstraZeneca and not ordered by any regulatory agency.
The nature of the adverse reaction and when it happened
were also not immediately known, though the participant is expected to recover, according to an individual familiar with the matter.